Is biceps augmentation effective for scope-assisted lower trapezius tendon transfer in posterosuperior irreparable rotator cuff tears? A retrospective short-term clinical comparison Authors: Chang Hee Baek, Bassem T Elhassan, Chaemoon Lim, Jung Gon Kim, Bo Taek Kim, Seung Jin Kim Published: 2026 ABSTRACT AbstractIntroductionAlthough favorable clinical outcomes of scope-assisted lower trapezius tendon transfer (SALTT) have been reported in posterosuperior irreparable rotator cuff tears (PSIRCTs) patients, the limited restoring of static stability can be supported by biceps augmentation as a static stabilizer. This study aimed to compare the outcomes of scope-assisted lower trapezius tendon transfer (SALTT) with and without biceps augmentation in patients with posterosuperior irreparable rotator cuff tears (PSIRCTs).Material and methodsThis retrospective clinical comparative study was performed with the inclusion criteria: patients who underwent SALTT for PSIRCT from January 2022 to April 2023; a follow-up period of more than 2 years; and availability for clinical assessment and MRI evaluation preoperatively and at 2 years postoperatively. The patients were grouped according to the management of biceps; Non-augmentation group (n = 26) and Augmentation group (n = 27). The clinical outcomes were evaluated using shoulder pain, patient-reported outcome measures (PROMs), and active range of motion (aROM). Radiological outcomes were performed to evaluate the progression of shoulder joint arthritis, biceps integrity, and graft integrity.ResultsBoth groups showed significant improvements in VAS score, PROMs, and aROM. Although postoperative PROMs of Non-augmentation group were significantly higher than Augmentation group, there was no significant difference in achievement of minimal clinically important difference. The postoperative abduction (p = 0.006) and external rotation (p = 0.024) of Non-augmentation group were significantly higher than Augmentation group. Although the rate of transferred graft rupture was higher in Augmentation group, there was no significant difference between the two groups. However, the rate of biceps rupture of Augmentation group was significantly higher than Non-augmentation group (p = 0.019).ConclusionBiceps augmentation did not yield significant improvements in clinical or radiologic outcomes in SALTT for PSIRCTs. Moreover, it may be associated with increased rates of biceps rupture.Level of evidenceLevel III.Keywords: Lower trapezius tendon transfer, Biceps augmentation, Irreparable rotator cuff tears Introduction The irreparable supraspinatus (SSP) and infraspinatus (ISP) may cause severe pain and dysfunction of shoulder, and rotator cuff arthropathy in posterosuperior irreparable rotator cuff tears (PSIRCTs) [11]. Joint saving treatment for IPSRCTs without arthritic change of the shoulder joint is acceptable [7]. Various surgical options for joint saving, such as superior capsular reconstruction (SCR), biceps rerouting, subacromial balloon spacer and tendon transfer have been introduced for PSIRCTs [23, 28, 30, 38]. Among them, scope-assisted lower trapezius tendon transfer (SALTT) have been used as biomechanical advantage and satisfactory clinical results have been well documented [5]. SALTT restores transverse plane force couple by substituting for the infraspinatus, as it closely mimics the natural line of pull of infraspinatus muscle [18, 31]. Recently, SALTT attached to supraspinatus footprint has been able to provide the functional fulcrum for deltoid functions by substituting the function of the supraspinatus across the full range of shoulder motion.[2, 3] With these biomechanical advantages, excellent clinical outcomes for short-term and mid-term follow-up periods have been reported in PSIRCTs [1, 14, 32]. Moreover, the restoration of dynamic force coupling may contribute to delaying the progression of arthritic changes in the glenohumeral joint [2]. Nevertheless, other cadaveric study have suggested that SALTT may have limitations in restoring static stability, particularly in terms of superior humeral head control [26]. Long head of biceps tendon (LHBT) stabilizes the humeral head in glenohumeral joint and prevents the migration of humeral head [20, 25]. Biceps augmentation during partial repair of massive rotator cuff tears has gained attention because it is less technically demanding, less expensive, locally available, and can be performed at the time of repair [22, 34]. However, there is controversy regarding the clinical outcomes of biceps augmentation. Several studies have reported that biceps augmentation yields good clinical outcomes along with a higher tendon healing rate compared to rotator cuff repair without biceps augmentation [5, 10, 37]. Other studies have reported that there is no significant difference in clinical outcomes and tendon healing rate between rotator cuff repair with biceps augmentation and without biceps augmentation [19, 33]. In several biomechanical studies, biceps augmentation restored superior static stability by preventing superior migration of humeral head and reducing deltoid force during abduction [17]. Recently, arthroscopic-assisted lower trapezius tendon transfer combined with long head of the biceps superior capsular reconstruction has been described as a technical procedure for massive irreparable posterosuperior rotator cuff tears [9]. However, clinical outcome data and comparative analyses regarding the role of biceps augmentation in SALTT remain limited. While SALTT provides dynamic stability and restores the transverse plane force couple, its ability to fully restore superior static stability remains debated. The purpose of this study was to compare the clinical and radiologic outcomes of SALTT with and without biceps augmentation. We hypothesized that biceps augmentation would enhance superior static stability, resulting in improved clinical and radiologic outcomes compared to SALTT alone. Materials and methods Patient population From January 2022 to April 2023, we conducted a retrospective comparative clinical study involving patients who underwent SALTT to treat PSIRCT. During the study period, all patients with PSIRCT who met the defined criteria underwent SALTT, as it is the standard surgical approach for PSIRCT at our institution. Therefore, the study cohort represents the entire population of surgically treated PSIRCT cases during this period. Patients were considered to have PSIRCT if they met the following criteria: (1) involvement of at least two rotator cuff tendons, including the SSP and ISP; (2) tendon retraction to the level of the glenoid, classified as Patte [35] stage III; (3) presence of severe fatty degeneration in the rotator cuff muscles, corresponding to Goutallier [16] grade III or IV based on preoperative MRI findings; and (4) deemed irreparable during surgery when the retracted tendons could not be returned to the footprint despite adequate mobilization and soft tissue release (Fig. 1). Diagnosis of posterosuperior rotator cuff tears. A Preoperative true anteroposterior radiograph shows no arthritis in the glenohumeral joint (Hamada classification grade I) of right shoulder. B Preoperative T2-weighted sagittal image of magnetic resonance imaging shows severe fatty infiltration of the supraspinatus (SSP) and infraspinatus (ISP) tendon. C The intraoperative arthroscopic image shows retracted torn rotator cuff tendons and intact biceps (asterisk) SALTT was indicated for patients who met the following criteria: (1) significant shoulder pain and/or functional impairment interfering with daily living; (2) persistent symptoms from PSIRCT unresponsive to conservative treatment for at least six months; (3) preservation or reparability of the subscapularis (SSC) tendon; (4) mild arthritic changes not exceeding Hamada grade 2; (5) absence of neurological impairments; and (6) sufficient understanding of the SALTT procedure, including its mechanism, potential benefits and limitations, and voluntary consent to undergo surgery. The decision on management of the biceps was influenced by various factors, such as biceps specific clinical presentation, physical examination, biceps pathology and patient’s willingness. If the patient complained about biceps specific clinical manifestation for physical examination or has biceps pathology, tenotomy or tenodesis of biceps was performed. Among the patients who have no biceps specific clinical presentation and biceps pathology, biceps non-augmentation or biceps augmentation were performed. Biceps augmentation was not performed during the initial study period from January 2022 to August 2022. However, from September 2022 to April 2023, biceps augmentation was performed in accordance with the reported advantages described in the literature. The inclusion criteria were (1) patients who underwent SALTT for PSIRCT from January 2022 to April 2023; (2) a follow-up period > 2 years and (3) availability for clinical assessment and MRI evaluation preoperatively and at least 2 years postoperatively. The exclusion criteria were (1) auto-tenotomy state of biceps; (2) tenotomy of biceps and (3) tenodesis of biceps. The patients were grouped according to the management of biceps; Non-augmentation group and Augmentation group. Age, sex, body mass index (BMI), smoking status, and medical comorbidity data were collected. Surgical technique All surgical procedures were performed by experienced senior surgeon (C.H.B). The patients were positioned in lateral decubitus position under general anesthesia with interscalene nerve block. The operative arm was draped and suspended in shoulder 20˚ forward elevation and 20˚ abduction with the lateral traction. The reparability of rotator cuff was evaluated during diagnostic arthroscopic examination. After confirming the PSIRCTS, the subacromial spur was decompressed to prevent the irritation of interpositional graft by subacromial spur during excursion of transferred lower trapezius (LT) tendon. The footprint of SSP and ISP was prepared until exposure of subchondral bone to promote the graft-bone healing. If there is a tear that requires suturing, subscapularis was repaired with a double row suture bridge technique. In case of biceps non-augmentation, the absence of pathology and the excursion of biceps were confirmed (Fig. 2A). On the other hand, in case of biceps augmentation, the biceps was tenotomized with a radiofrequency device in subpectoral area. The distal portion of the tenotomized biceps was fixed using a arthroscopic subpectoral tenodesis technique with FiberWire. The proximal portion of tenotomized biceps was augmented after fixation of the interpositional graft of SALTT. Arthroscopic image of scope-assisted lower trapezius tendon transfer with/without biceps augmentation. A Arthroscopy image of right shoulder of Non-augmentation group shows the interpositional graft (arrowhead) with the non-augmented biceps (asterisk). B Arthroscopy image of right shoulder of Augmentation group shows the interpositional graft (arrowhead) with augmented biceps (asterisk) After preparing for SALLT, the LT tendon was harvested. Surface anatomy of scapula including scapular spine, medial border of scapular body and inferior pole was marked. A skin incision of 8 ~ 10 cm length was made obliquely from the middle of scapular spine to middle of medial border of scapular body. After removal of subcutaneous fat tissue, the LT tendon could be distinguished. The triangular muscle portion of LT tendon was detached from the middle trapezius tendon and scapular spine. The lateral end of harvested LT tendon was sutured with Krakow method. After harvesting the LT tendon, the interpostional graft was prepared with Achilles tendon allograft (ATA). The ATA were folded two to three times to achieve the desired graft size, ensuring a thickness of at least 6 mm, a width of at least 2 cm, and a length of at least 15 cm. One side of ATA was prepared using the Krakow suture technique. The other side of the Achilles tendon allograft will be sutured to the inferior margin of the LT tendon using Krakow suture technique. Two medial-row anchors were inserted into the SSP footprint and near the articular margin of the greater tuberosity. Three threads of posterior medial-row anchors were passed through the posterior remnant ISP cuff using Suture Lasso for side-to-side sutures with the interpositional graft. The remaining threads were drawn out of the joint through the lateral portal and passed through the interpositional graft to attach it to the SSP footprint. A large grasping clamp was inserted from the lateral portal to the infraspinatus fascia of the scapular skin incision for passage of the interpositional graft. The Krakow suture of prepared side of the interpositional graft was grasped and pulled through the lateral portal. After placing the interpositional graft on the SSP footprint, it was fixed with the two previously inserted anchors using the double-row suture bridge technique. Subsequently, a side-to-side suture was made by passing threads through the posterior remnant cuff and interpositional graft. Three lateral-row anchors were inserted at the anterolateral, middle-lateral and posterolateral aspect of the greater tuberosity in a suture bridge technique. In case of biceps augmentation, a suture anchor was inserted into the footprint right in front of interpositional graft. Sutures of this anchor were passed through the proximal portion of tenotomized biceps and tied to cover the rotator cuff defect on the SSP footprint. These tied sutures were passed through the anterior edge of the interpositional graft and tied for augmentation (Fig. 2B). After fixation of the interpositional graft on the footprint, the unprepared side of interpositional graft was attached to the inferior margin of the lower trapezius using the Krakow technique to render the line of the pull of the LTT which was similar to the physiological line of pull of the native infraspinatus. Anastomosis was performed with the shoulder in neutral rotation with a 60° shoulder abduction. Postoperatively, patients wore a shoulder brace for six weeks. After this period, they began a passive range of motion (ROM) exercises, which continued for four weeks. Subsequently, patients transitioned to active ROM (aROM) exercises and started gentle strengthening exercises. By six months postoperative, patients were encouraged to resume high-level activities. Clinical evaluation The clinical outcomes were evaluated using shoulder pain, patient-reported outcome measures (PROM), and active range of motion (aROM). Shoulder pain was evaluated using a Visual Analog Scale (VAS) score. Constant-Murley score, American Shoulder and Elbow Surgeons (ASES) score, and activities of daily living requiring active external rotation (ADLER) score were used as a PROM. The primary outcome was the Constant-Murley score, which reflects overall shoulder function, including pain, activity, strength, and range of motion. The minimal clinically important difference (MCID) of the Constant score and ASES were 10.4 and 15.2, respectively. [24, 27] The MCID for ADLER (3.3) was calculated by ½ standard deviation (SD) of the delta between preoperative ADLER score and postoperative ADLER score. aROM was assessed in four directions: forward elevation (FE), abduction (ABD), external rotation (ER), and internal rotation (IR). For FE, ABD, and ER, the angle at the end of the motion was measured using a standard goniometer, while IR was determined by asking the patient to move their arm behind their back and noting the highest vertebral level their thumb reached (0, greater trochanter; 2, buttock; 4, lumbosacral junction; 6, L3; 8, T12; 10, T7). All clinical outcomes were assessed preoperatively, as well as at 3 months, 6 months, and 1 year postoperatively, and then evaluated every 6 months thereafter. Because the biceps augmentation or biceps non-augmentation were performed during different time frames of this study periods, clinical outcomes were compared using follow-up data limited to within 2 years postoperatively to standardize the observation window and minimize temporal bias. Final clinical results were analyzed by comparing baseline (preoperative) findings with those at the last follow-up. All clinical outcomes were objectively assessed by a research coordinator who blinded the patient's information and the details of this study. Radiologic evaluation Radiological outcomes were performed to evaluate the progression of shoulder joint arthritis, biceps integrity, and graft integrity. Shoulder joint arthritis was assessed using the acromiohumeral distance (AHD), Hamada grade, and the progression of osteoarthritis (OA). The progression of shoulder joint OA was defined as a postoperative Hamada grade advancing to 3 or 4. The AHD and Hamada grade were assessed preoperatively, as well as at 1 months, 3 months, 6 months, and 1 year postoperatively, and then evaluated every 6 months thereafter. Biceps integrity and transferred graft integrity were evaluated on MRI (Fig. 3). Biceps integrity was evaluated on MRI by examining the long head of the biceps throughout its course Specifically, continuity was assessed to determine whether the tendon is intact or shows disruptions or discontinuity suggestive of biceps rupture (Fig. 4). Transferred graft integrity was assessed using the Sugaya Classification which was used to evaluate the integrity of the rotator cuff or graft on postoperative MRI. A graft was considered as ruptured if there was any discontinuity corresponding to Sugaya Classification IV or V at the humeral attachment or mid-substance of graft (Fig. 5). The MRIs were obtained preoperatively, as well as at 1 month, 6 months, and 1 year postoperatively, and then conducted annually thereafter. Because the biceps augmentation or biceps non-augmentation were performed during different time frames of this study periods, radiologic outcomes were compared using follow-up data limited to within 2 years postoperatively to standardize the observation window and minimize temporal bias. Radiologic evaluation was compared between the preoperative assessment and the radiologic outcomes observed at the final follow-up. All radiologic outcomes were objectively assessed by an experienced musculoskeletal radiologic specialist who blinded the patient's information and the details of this study. Postoperative magnetic resonance image (MRI) of scope-assisted lower trapezius tendon transfer with/without biceps augmentation. A Postoperative T2-weighted sagittal MRI right shoulder of Non-augmentation group shows the interpositional graft (arrowhead) with the non-augmented biceps (asterisk). B Postoperative T2-weighted sagittal MRI of right shoulder of Augmentation group shows the interpositional graft (arrowhead) with augmented biceps (asterisk) The evaluation of biceps integrity on magnetic resonance image (MRI). A Postoperative 1-month T2-weighted sagittal MRI of right shoulder of Non-augmentation group shows the intact Augmented biceps (asterisk). B Postoperative 1-year T2-weighted sagittal MRI of right shoulder of Augmentation group shows the ruptured Augmented biceps (arrow) The evaluation of transferred graft integrity on magnetic resonance image (MRI). A Postoperative 1-month T2-weighted sagittal MRI of right shoulder shows the intact transferred graft (arrowhead). B Postoperative 1-year T2-weighted sagittal MRI of right shoulder shows the ruptured (asterisk) transferred graft (arrowhead) Statistical analysis Normality of continuous variables was assessed with the Shapiro–Wilk test. Because several distributions violated normality (P < 0.05), nonparametric procedures were used. Within-subject pre–post comparisons employed the Wilcoxon signed-rank test, and paired categorical outcomes were evaluated with McNemar’s test. Between-group comparisons of continuous data used the Mann–Whitney U test, and categorical variables were analyzed using Fisher’s exact test. Although nonparametric analyses were applied, results are reported as mean ± standard deviation (SD) to enhance clinical interpretability and comparability with prior studies. Two-sided P values < 0.05 were considered statistically significant. All analyses were performed in SPSS Statistics, version 21.0 (IBM Corp., Armonk, NY, USA). Interobserver reliability for AHD measurements and Hamada grading was assessed using the intraclass correlation coefficient (ICC). Two independent authors (B.T.K. and J.G.K.) performed measurements of preoperative and final follow-up AHD and Hamada grades to determine inter-rater agreement. Results The patients who were auto-tenotomy state of biceps (n = 6) or underwent biceps tenotomy (n = 5) or biceps tenodesis (n = 2) were excluded. Finally, 26 patients who underwent SALTT with non-augmentation of biceps (Non-augmentation group) and 27 patients who underwent SALTT with augmentation of biceps (Augmentation group) were included for the study population (Fig. 6). No significant intergroup difference was confirmed in patient demographics, underlying diseases, FI grade of rotator cuff and SSC management (Table 1). Flowchart SALTT, scope-assisted lower trapezius tendon; PSIRCT, posterosuperior irreparable rotator cuff tear; MRI, magnetic resonance image. (Initially, 6 patients were not included due to a follow-up period of less than 2 years or unavailability of both clinical and MRI evaluations) Table 1Demographic and clinical characteristicsVariablesNon-augmentation groupAugmentation grouppNumber of patients2627Age, mean ± SD, yr64.0 ± 6.764.4 ± 6.40.936Female, %12 (46.2)11 (40.7)0.785BMI, mean ± SD, kg/m225.3 ± 3.623.5 ± 2.70.111Arm dominance, n (%)14 (53.8)16 (59.3)0.785Smoking, n (%)2 (7.7)3 (11.1)0.607Diabetes mellitus, n (%)3 (11.5)3 (11.1)1.000Hypertension, n (%)6 (23.1)5 (18.5)0.745Previous cuff repair, n (%)5 (19.2)7 (25.9)0.728Preop-Hamada grade, mean ± SD1.1 ± 0.31.1 ± 0.30.961 Grade 1, n (%)13 (88.5)24 (88.9)1.000 Grade 2, n (%)3 (11.5)3 (11.1)SSC FI grade, mean ± SD1.2 ± 0.41.4 ± 0.50.273 Grade 1, n (%)20 (76.9)17 (63.0)0.372 Grade 2, n (%)6 (23.1)10 (37.0)SSP FI grade, mean ± SD3.5 ± 0.53.5 ± 0.50.681 Grade 3, n (%)14 (53.8)13 (48.1)0.786 Grade 4, n (%)12 (46.2)14 (51.9)ISP FI grade, mean ± SD3.7 ± 0.53.7 ± 0.50.829 Grade 3, n (%)7 (26.9)8 (29.6)1.000 Grade 4, n (%)19 (73.1)19 (70.4)Tm FI grade, mean ± SD1.6 ± 1.11.5 ± 0.90.955 Grade 1, n (%)17 (73.1)20 (74.1)0.915 Grade 2, n (%)2 (7.7)3 (11.1) Grade 3, n (%)2 (7.7)2 (7.4) Grade 4, n (%)3 (11.5)2 (7.4)SSC repair5 (19.2)7 (25.9)0.745SD Standard deviation, BMI Body mass index, FI Fat infiltration, SSC Subscapularis, SSP Supraspinatus, ISP Infraspinatus, Tm Teres minorSignificant p-value is < 0.05 Demographic and clinical characteristics SD Standard deviation, BMI Body mass index, FI Fat infiltration, SSC Subscapularis, SSP Supraspinatus, ISP Infraspinatus, Tm Teres minor Significant p-value is < 0.05 In clinical outcomes, both groups showed significant postoperative improvements in VAS score, PROMs, and aROM. There was no significant difference in postoperative VAS score between the two groups. The primary outcome, postoperative Constant-Murley score (67.6 ± 14.9 vs 58.2 ± 13.6, p = 0.002) of Non-augmentation group were significantly higher than that of Augmentation group. However, there was no significant difference in achievement of MCID for Constant-Murley between two groups. The postoperative ASES score (76.1 ± 15.6 vs 64.6 ± 14.9, p = 0.008) and ADLER score (74.9 ± 15.1 vs 63.4 ± 16.7, p = 0.003) of Non-augmentation group were significantly higher than that of Augmentation group. However, there was no significant difference in achievement of MCID for ASES and ADLER score between two groups (Table 2). In aROM, although there was no significant difference in postoperative FE between two groups, the postoperative ABD (150.4 ± 28.9 vs 122.6 ± 38.9, p = 0.021) and ER (43.1 ± 17.8 vs 33.1 ± 14.0, p = 0.047) of Non-augmentation group were significantly higher than that of Augmentation group (Table 3). Table 2Comparisons of pain and patient-reported clinical score between two groupsVariablesNon-augmentation groupAugmentation grouppVAS score Preoperative4.3 ± 1.34.6 ± 1.20.285 Postoperative1.3 ± 0.61.9 ± 1.10.057 P < 0.001 < 0.001Constant score Preoperative41.2 ± 7.441.1 ± 9.30.538 Postoperative67.6 ± 14.958.2 ± 13.60.002 P < 0.001 < 0.001ASES score Preoperative45.1 ± 6.843.7 ± 7.70.459 Postoperative76.1 ± 15.664.6 ± 14.90.002 P < 0.001 < 0.001ADLER Preoperative46.7 ± 12.643.2 ± 8.20.125 Postoperative74.9 ± 15.163.4 ± 16.70.003 P < 0.001 < 0.001MCID for constant, n (%)0.544 Success20 (76.9)18 (66.7) Failure6 (23.1)9 (33.3)MCID for ASES, n (%)0.757 Success20 (76.9)19 (70.3) Failure6 (23.1)8 (29.7)MCID for ADLER, n (%)0.669 Success24 (92.3)23 (88.5) Failure2 (7.7)4 (11.5)VAS Visual analogue scale, ASES American shoulder and elbow surgeons, ADLER Activities of daily living requiring active external rotation, MCID Minimal clinically important differenceSignificant p-value is < 0.05 Comparisons of pain and patient-reported clinical score between two groups VAS Visual analogue scale, ASES American shoulder and elbow surgeons, ADLER Activities of daily living requiring active external rotation, MCID Minimal clinically important difference Significant p-value is < 0.05 Table 3Comparisons of active range of motion between two groupsVariablesNon-augmentation groupAugmentation grouppFE, Preoperative111.5 ± 12.9106.7 ± 15.20.359 Postoperative156.9 ± 28.3138.9 ± 36.80.059 P < 0.0010.001ABD, ˚ Preoperative105.0 ± 18.8104.1 ± 30.50.602 Postoperative150.4 ± 28.9122.6 ± 38.90.006 P < 0.0010.014ER at 0˚ of abduction, ˚ Preoperative17.3 ± 9.217.2 ± 6.10.659 Postoperative43.1 ± 17.833.1 ± 14.00.024 P < 0.001 < 0.001IR at back Preoperative6.6 ± 1.76.3 ± 1.40.211 Postoperative6.2 ± 1.36.6 ± 1.40.297 P0.6260.163Pseudoparalysis, n (%) Preoperative4 (15.4)5 (18.5)0.845 Postoperative1 (3.8)4 (14.8)0.287 P0.4390.650FE Forward elevation, ER External rotation, IR Internal rotation, internal rotation was measured as the level that could be reached by the thumb (0, greater trochanter; 2, buttock; 4, lumbosacral junction; 6, L3; 8, T12; 10, T7)Significant p-value is < 0.05 Comparisons of active range of motion between two groups FE Forward elevation, ER External rotation, IR Internal rotation, internal rotation was measured as the level that could be reached by the thumb (0, greater trochanter; 2, buttock; 4, lumbosacral junction; 6, L3; 8, T12; 10, T7) Significant p-value is < 0.05 Although AHD significantly increased postoperatively in both groups, the small magnitude of change, near the measurement error range, may limit its clinical significance. There was no significant difference in postoperative AHD, Hamada grade and OA progression between the two groups. Although the rate of transferred graft rupture was higher in Augmentation group, there was no significant difference between the two groups. However, the rate of biceps rupture of Augmentation group was significantly higher than that of Non-augmentation group (p = 0.0040, Fig. 7, Table 4). The rupture pattern consistently demonstrated discontinuity of the tendon substance, while the suture interface and anchor fixation remained intact. The interobserver reliability for preoperative and postoperative AHD (ICCpre-AHD = 0.92 [0.83–0.94], p < 0.001, ICCpost-AHD = 0.94 [0.86–0.93], p < 0.001) and Hamada grade (ICCpre-Hamada = 0.88 [0.80–0.90], p < 0.001, ICCpost-Hamada = 0.92 [0.87–0.97], p < 0.001) were all excellent. The evaluation of biceps integrity and transferred graft integrity into second-look arthroscopy. A Initially intraoperative arthroscopy of right shoulder shows the transferred graft (arrowhead) with the non-augmented biceps (asterisk) of Non-augmentation group. B Second-look arthroscopy of right shoulder during adhesiolysis shows the intact transferred graft (arrowhead) and intact non-augmented biceps (asterisk) of Non-augmentation group. C Initially intraoperative arthroscopy of right shoulder shows the transferred graft (asterisk) with the augmented biceps (arrow) of Augmentation group. D Second-look arthroscopy of right shoulder during adhesiolysis shows the ruptured transferred graft (asterisk) and ruptured augmented biceps of augmentation group Table 4Radiologic outcome between the two surgical groupsVariablesNon-augmentation groupAugmentation grouppAHD (mm) Preoperative8.1 ± 1.48.1 ± 2.00.901 Postoperative8.4 ± 1.48.4 ± 2.40.961 P0.0420.049Postop-Hamada grade, mean ± SD1.2 ± 0.51.4 ± 0.70.243 Grade 1, n (%)21 (80.8)18 (66.7)0.698 Grade 2, n (%)4 (15.4)7 (25.9) Grade 3, n (%)1 (3.8)1 (3.7) Grade 4, n (%)0 (0.0)1 (3.7)Progression of arthritic change, n (%)1 (3.8)2 (7.4)1.000Transferred graft rupture, n (%)1 (3.8)6 (22.2)0.142Biceps rupture, n (%)2 (7.6)10 (37.0)0.019SD Standard deviation, AHD Acromiohumeral distanceSignificant p-value is < 0.05 Radiologic outcome between the two surgical groups SD Standard deviation, AHD Acromiohumeral distance Significant p-value is < 0.05 Among postoperative complications, one patient in the Non-augmentation group developed an infection, which was effectively managed with antibiotic therapy. In the Augmentation group, a case of postoperative hematoma occurred and was resolved with conservative treatment. Additionally, one patient from each group experienced adhesive capsulitis after surgery, both of which were successfully treated through arthroscopic adhesiolysis. Discussion In this study, there were significant improvements in clinical and radiologic outcomes in the Non-augmentation group and Augmentation group. Comparing the two groups, it seems that biceps augmentation did not provide any additional advantage, with some PROM (Constant-Murley score and ASES score) and aROM (ABD and ER) showing more significant improvement in the Non-augmentation group. Moreover, although there was no significant difference, the rate of transferred graft rupture was higher in the Augmentation group. The rate of biceps rupture was significantly higher in the Augmentation group. As a result, the biceps augmentation did not show superior clinical and radiologic outcomes in SALTT for PSIRCTs. SALTT has emerged as a promising surgical option for managing PSIRCTs by re-establishing the force couple and enhancing humeral head stability [15]. Favorable clinical and radiologic outcomes have been reported in previous short- and mid-term studies, which are largely attributed to its biomechanical advantages [1, 14]. Biomechanical studies have demonstrated that SALTT can restore the compressive-distractive joint reaction forces and anterior–posterior force couples of the glenohumeral joint, contributing to more physiologic shoulder kinematics [36]. Furthermore, transfer of the lower trapezius tendon through the subacromial space to the supraspinatus footprint may provide a static stabilizing effect and spacer function [4]. These mechanisms likely contribute to improved shoulder function and delayed progression of glenohumeral arthritis following SALT [2]. However, cadaveric studies have also suggested that SALTT may have limited ability to restore superior static stability, as it does not fully replicate the spacer effect of the native superior capsule [26]. Biceps augmentation was widely used because it provides better structural support and decreases the chance of failure for rotator cuff repair [10]. Moreover, biceps augmentation is technically simpler, cost-effective, and readily availabl.[34] The primary purpose of biceps augmentation is to provide structural stability by covering the rotator cuff footprint [8]. In biceps augmentation, the biceps serves as an autograft to fill the footprint defect caused by a rotator cuff tear, thereby reducing the defect size and enabling rotator cuff repair without tension [29]. In several biomechanical studies, biceps augmentation restored superior static stability by preventing superior migration of humeral head and reducing deltoid force during abduction [17]. Several clinical studies reported favorable clinical outcomes including significant improvement of pain relief, PROM and ROM of shoulder in rotator cuff repair [8, 10]. Moreover, the healing rate of repaired rotator cuff was significantly improved after biceps augmentation [5]. As a result, biceps augmentation has gained popularity because of its biomechanical advantage and favorable clinical outcome. In this study, we thought that the limited restoring of static stability can be supported by biceps augmentation as a static stabilizer. We hypothesized that SALTT with biceps augmentation would show a better clinical and radiologic outcome by superior static stability than that of SALTT without biceps augmentation. However, biceps augmentation provided no significant improvement of clinical and radiologic outcomes in SALTT for PSIRCTs. Similar to our study, recent studies have increasingly reported no significant difference in outcomes between rotator cuff repair with and without biceps augmentation [19, 33]. These studies reported that biceps augmentation did not achieve an enough spacer effect that maintains the humeral head in the center of the glenoid [19, 33]. Furthermore, given that the biceps tendon averages about 6.6 mm in thickness, it might not provide sufficient structural support to re-establish a stable fulcrum in the glenohumeral joint [21]. Duralde et al. demonstrated that re-establishing a stable fulcrum is more critical for normal shoulder kinematics than simply covering the footprint defect in rotator cuff repair [13]. In SALTT for PSIRCTs, the static spacer effect of biceps augmentation may be less important than restoring the transverse plane force couple and stable fulcrum. The static spacer effect of biceps augmentation may not be sufficient to have clinical significance in SALTT for PSIRCTs. In this study, the augmentation group showed a higher rate of transferred graft rupture (although not statistically significant) and a higher incidence of biceps rupture. From a biomechanical perspective, this may be explained by altered force transmission following augmentation. In its native state, the long head of the biceps tendon (LHBT) maintains relative mobility within the bicipital groove and contributes to dynamic stabilization [22]. However, when fixed anterior to the interpositional graft in a side-to-side fashion, its physiologic excursion may be limited. During shoulder abduction and external rotation, the posteriorly directed force of the transferred lower trapezius may generate increased tensile and shear stress at the suture interface of the anteriorly fixed biceps, leading to stress concentration within the tendon substance or fixation site [32]. Notably, all biceps ruptures occurred within the tendon substance rather than at the suture interface or anchor fixation site. This finding suggests that structural failure was less likely attributable to technical fixation issues and may instead reflect excessive mechanical loading on the tendon itself. In addition, Dogramaci et al. reported that tendon-to-tendon healing occurs only in end-to-end anastomosis, whereas other types of anastomoses result in the formation of only a thick fibrovascular sheet [12]. Similarly, although the biceps was anastomosed with interpositional graft using a side-to-side suture, tendon-to-tendon healing may not have occurred in this study. Bilgin et al. demonstrated that the biceps experiences the least pressure when it is in a more mobile state within the bicipital groove, and the pressure exerted on the biceps during augmentation is crucial for successful healing [6]. However, in this study, the biceps was relocated from the bicipital groove to achieve footprint coverage and was fixed to an interpositional graft with excursion, which may have resulted in increased pressure during the range of motion. Ultimately, the lack of tendon-to-tendon healing between the biceps and the interpositional graft, along with the high pressure exerted on the biceps, may have contributed to the higher rate of transferred graft rupture and biceps rupture. Although the difference in rate of transferred graft rupture between the two groups did not reach statistical significance, the relatively higher rupture rate of the Augmentation group may have contributed to the lower postoperative ABD and ER seen in this group. This study has several limitations. First, as a retrospective and non-randomized design, it is inherently subject to selection bias. Additionally, patients who were lost to follow-up were excluded, which may have influenced the final analysis. Second, the sample size was relatively small, and the follow-up period was limited to a short-term assessment. Although statistically significant differences were identified, the study may have been underpowered to detect more subtle effects or rare complications. Third, the allocation to the augmentation and non-augmentation groups occurred during different time frames, introducing potential temporal bias despite efforts to standardize outcome assessment within a two-year postoperative window. Furthermore, because the non-augmentation group was treated earlier than the augmentation group, the possibility of a learning curve effect cannot be entirely excluded. However, all procedures were performed by an experienced senior surgeon, and SALTT had already been routinely performed at our institution prior to the initiation of this study, which may mitigate—but not eliminate—this potential bias. In addition, although patients with structural biceps pathology were excluded to minimize baseline differences, the decision regarding biceps augmentation was influenced in part by treatment protocol and patient-related factors. Therefore, potential confounding related to patient expectations, motivation, or postoperative compliance cannot be entirely excluded. This inherent limitation of the retrospective and non-randomized design may have influenced the observed outcomes. Finally, because this study was conducted at a single institution by a single surgeon, the findings may not be generalizable to broader patient populations or different surgical settings. Further prospective, multi-center studies with larger sample sizes and longer follow-up periods would be beneficial to validate these results and to better define the role of biceps augmentation in SALTT. Conclusion Biceps augmentation did not yield significant improvements in clinical or radiologic outcomes in SALTT for PSIRCTs. Moreover, it may be associated with increased rates of biceps rupture. Acknowledgements None. Author contribution Conceptualization: CHB, BTE, CL, JGK, BTK Investigation: CHB, BTE, CL, JGK, BTK, SJK Methodology: CHB, BTE, CL, JGK, BTK, SJK Resources: CL, JGK, BTK Supervision: CHB, CL Validation: CHB, BTE, CL, JGK, BTK Visualization: CL, SJK Writing – original draft: CL Writing – review & editing: CHB, CL. Funding No funds, grants, or other support was received. Data availability No datasets were generated or analysed during the current study. Declarations Conflict of interest The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.